Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).

OBJECTIVE

To evaluate the biliary complication rates and efficacy of peribiliary tumor ablation using irreversible electroporation (IRE) or radiofrequency ablation (RFA).

MATERIAL AND METHODS

This is a retrospective study of 42 consecutive patients with 44 peribiliary tumors (≤5 mm distance between the tumor margin and the primary or secondary bile duct). Data were collected between January 2014 and September 2020 from patients who underwent percutaneous liver ablation using IRE ( = 13) or RFA ( = 31).

RESULTS

The median length of follow-up was 23.1 months. The mean tumor size was 17.2 ± 5.2 mm in IRE 18.4 ± 7.0 mm in RFA (= .56). Complete tumor ablation was achieved in 100% with a significantly larger ablation zone in the IRE group (3.8 ± 0.3 cm 2.6 ± 0.6 cm, <.001). Significant biliary complications occurred in one patient (7.7%) of the IRE group and in five patients (16.1%) of the RFA group. Significant risk factors for biliary complications included the RFA procedure (HR 9.71, =.032) and proximity of the tumor to the bile duct (HR 0.63, =.048). The local tumor progression (LTP) rates were 7.7% (IRE) 21.5% (RFA) at 1 year, 23.1% (IRE) 32.7% (RFA) at 2 years and 23.1% (IRE) 44% (RFA) at 3 years, respectively (=.289).

CONCLUSIONS

The IRE and RFA procedures are safe and effective to treat peribiliary liver tumors. However, the RFA may have a higher risk of significant bile duct injury than IRE. The shorter distance between the bile duct and the tumor is a strong risk factor for biliary complications.